ICD-10 Indication | ICD-10 Code |
---|---|
... with other complication | K51.918 |
... with unspecified complications | K51.919 |
ICD-10-CM 2020: The Official Codebook. American Medical Association, 2019. STELARA ® (ustekinumab) is indicated for the treatment of adult patients with active psoriatic arthritis. STELARA ® can be used alone or in combination with methotrexate (MTX).
O36 ICD-10-CM Diagnosis Code O36. Maternal care for other fetal problems 2016 2017 2018 2019 Non-Billable/Non-Specific Code. Includes the listed conditions in the fetus as a reason for hospitalization or other obstetric care of the mother, or for termination of pregnancy.
Intrauterine growth restriction ICD-10-CM O36.5990 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 817 Other antepartum diagnoses with o.r. Procedures with mcc 818 Other antepartum diagnoses with o.r. Procedures with cc
The 2022 edition of ICD-10-CM E23.6 became effective on October 1, 2021. This is the American ICD-10-CM version of E23.6 - other international versions of ICD-10 E23.6 may differ. All neoplasms, whether functionally active or not, are classified in Chapter 2.
Effective January 1, 2018, the product-specific HCPCS code for STELARA® is J3358, ustekinumab, for intravenous injection, 1 mg. It is important to note that this code represents 1 mg or 1/130th of a vial.
ICD-10 Codes for Long-term TherapiesCodeLong-term (current) use ofZ79.899other drug therapyH – Not Valid for Claim SubmissionZ79drug therapy21 more rows•Aug 15, 2017
ICD-10 code Z51. 81 for Encounter for therapeutic drug level monitoring is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Medicare will no longer cover STELARA SQ injections under the medical benefit (Part B) and instead will cover STELARA SQ under the prescription benefit (Part D).
Here are three steps to ensure you select the proper ICD-10 codes:Step 1: Find the condition in the alphabetic index. Begin the process by looking for the main term in the alphabetic index. ... Step 2: Verify the code and identify the highest specificity. ... Step 3: Review the chapter-specific coding guidelines.
ICD-10 CM Guidelines, may be found at the following website: https://www.cdc.gov/nchs/icd/Comprehensive-Listing-of-ICD-10-CM-Files.htm.
ICD-10 code T80 for Complications following infusion, transfusion and therapeutic injection is a medical classification as listed by WHO under the range - Injury, poisoning and certain other consequences of external causes .
Encounter for therapeutic drug level monitoring. Z51. 81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Persons encountering health services in other specified circumstancesZ76. 89 is a valid ICD-10-CM diagnosis code meaning 'Persons encountering health services in other specified circumstances'. It is also suitable for: Persons encountering health services NOS.
Eligible patients using commercial or private insurance can save on out-of-pocket medication costs for STELARA®. Eligible patients pay $5 per dose, with a $20,000 maximum program benefit per calendar year. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications.
Nationally, nearly all Part D plans cover at least one biologic DMARD, but the vast majority require sufficiently high cost sharing to risk significant financial burden to patients.
STELARA® is the only biologic that blocks the IL-12 and IL-23 proteins, which are part of the immune system, and are thought to play a role in plaque psoriasis. See how STELARA® works from the inside out with this video.